Phase I-II-III studies of Cisplatin and Combretastatin (CA4P) in recurrent or advanced cervical cancer

Trial Profile

Phase I-II-III studies of Cisplatin and Combretastatin (CA4P) in recurrent or advanced cervical cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Nov 2012

At a glance

  • Drugs Cisplatin (Primary) ; Fosbretabulin (Primary)
  • Indications Cervical cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 Nov 2012 Additional lead trial centre identified as reported by European Clinical Trials Database record.
    • 02 Nov 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2004-001356-37).
    • 09 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top